The Administrative Core (Core A) of the Johns Hopkins Alzheimer's Disease Research Center (ADRC) will be responsible for the overall management of the ADRC, by providing an environment that fosters new avenues of clinical and basic research, trains new investigators, and creates increased productivity in research related to AD. To accomplish this overarching goal it will: (1) coordinate and integrate the ADRC Cores and individual research Projects, as well as studies that are associated with the ADRC that are related to the Center mission;(2) interact with other Alzheimer Centers, the National Alzheimer Coordinating Center (NACC) and other national collaborative activities, in order to maximize progress in AD research throughout the country;(3) oversee the Pilot Project program that provides seed funding for promising research proposals by coordinating: announcements about the program to the scientific community, the review and selection of the projects to be funded (with approval by the NIA), and oversight of the scientific productivity of the funded projects;(4) interact with the lay community to further the goals ofthe ADRC, including the coordination of media outreach by the Center, as well as with the National Institute on Aging;(5) review the utilization of funds and resource allocation that supports the research, training and data management/statistical enterprises ofthe ADRC;and (5) insure compliance with JHU and NIH policies concerning protection of human subjects, animal welfare, ethical conduct of behavior, financial requirements, and the sharing of data, samples and model organisms. In order to maintain the excellence ofthe Center the Administrative Core will coordinate annual reviews by both an External and Internal Advisory Committee.

Public Health Relevance

The Johns Hopkins Alzheimer's Disease Research Center (ADRC) will address many ofthe topics important to dementia research, with a particular focus on the understanding the eariiest phases of Alzheimer's disease (AD). This approach is important if we are ultimately going to be able to diagnose and treat AD as eariy as possible. The ADRC fosters interactions among scientists who are pursuing this overarching theme.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005146-30
Application #
8448147
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4)
Project Start
Project End
Budget Start
2013-04-01
Budget End
2014-03-31
Support Year
30
Fiscal Year
2013
Total Cost
$166,763
Indirect Cost
$65,079
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Seddighi, Sahba; Varma, Vijay R; An, Yang et al. (2018) SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging. J Alzheimers Dis 61:401-414
Fredericks, Carolyn A; Sturm, Virginia E; Brown, Jesse A et al. (2018) Early affective changes and increased connectivity in preclinical Alzheimer's disease. Alzheimers Dement (Amst) 10:471-479
Holingue, Calliope; Wennberg, Alexandra; Berger, Slava et al. (2018) Disturbed sleep and diabetes: A potential nexus of dementia risk. Metabolism 84:85-93
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
van Bergen, Jiri M G; Li, Xu; Quevenco, Frances C et al. (2018) Low cortical iron and high entorhinal cortex volume promote cognitive functioning in the oldest-old. Neurobiol Aging 64:68-75
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Kim, Sangjune; Yun, Seung Pil; Lee, Saebom et al. (2018) GBA1 deficiency negatively affects physiological ?-synuclein tetramers and related multimers. Proc Natl Acad Sci U S A 115:798-803
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Hohman, Timothy J; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. JAMA Neurol 75:989-998

Showing the most recent 10 out of 830 publications